DJIA 15,973.84 313.66 2.00%
NASDAQ 4,337.51 70.68 1.66%
S&P 500 1,864.78 35.70 1.95%
market minute promo

Derma Sciences, Inc. (NASDAQ: DSCI)

3.05 -0.07 (-2.24%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

DSCI $3.05 -2.24%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.14
Previous Close $3.12
Daily Range $3.03 - $3.22
52-Week Range $2.85 - $9.23
Market Cap $78.7M
P/E Ratio -2.08
Dividend (Yield) $0.00 (0.0%)
Volume 109,795
Average Daily Volume 143,527
Current FY EPS -$1.41




Healthcare IT

Derma Sciences, Inc. (DSCI) Description

Derma Sciences Inc. is a medical technology company focused on three segments of wound care which includes pharmaceutical wound care advanced wound care and traditional wound care products. Website:

News & Commentary

The Changing Landscape in Chronic Diabetic Foot Ulcers

After the release of phase 3 data, Osiris Pharmaceuticals has just changed the dynamics of the chronic diabetic foot ulcer market. Other companies will, of course, be affected by Osiris' clinical data.

Becton, Dickinson Beats Q1 Earnings, FY16 View Raised

CONMED Beats Q4 Earnings & Sales, FY16 View Impressive

Halyard Health (HYH) Cut to Strong Sell on Estimate Revision

Is Derma Sciences (DSCI) Stock a Solid Choice Right Now?

New Strong Buy Stocks for December 11th

How Derma Sciences (DSCI) Stock Stands Out in a Strong Industry

Derma Sciences (DSCI) Stock Falls After Ending Drug Trial

Morning Market Losers

Derma Sciences' (DSCI) CEO Ed Quilty on Q3 2015 Results - Earnings Call Transcript

Why Halyard Health (HYH) Could Be Positioned for a Slump

See More DSCI News...

DSCI's Top Competitors

DSCI $3.05 (-2.24%)
Current stock: DSCI
$0.00 (0.00%)
Current stock:
MDT $73.40 (1.07%)
Current stock: MDT
COV $0.00 (0.00%)
Current stock: COV